EVpedia 2.0

This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:

Superdomain: All Prokaryote Eukaryote

Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).

Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.

Number of molecules in one page:

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name	miRBase accession	FPR	TPR	Publication	Orthologous group	Identification count All / Prokaryote / Eukaryote (FPR<0.05,TPR<0.5)
vvi-miR160a	MIMAT0005651	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000032_1	3 / 0 / 3
vvi-miR160b	MIMAT0005652	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000032_1	3 / 0 / 3
vvi-miR171f	MIMAT0005696	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000030_1	11 / 0 / 11
vvi-miR390	MIMAT0005707	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000101_1	3 / 0 / 3
vvi-miR399f	MIMAT0006567	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000015_1	9 / 0 / 9
vvi-miR399g	MIMAT0005731	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000015_1	9 / 0 / 9
vvi-miR482	MIMAT0006576	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000403_1	6 / 0 / 6
xtr-let-7a	MIMAT0003667	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000002_1	115 / 0 / 115
xtr-miR-129	MIMAT0003590	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000073_1	21 / 0 / 21
xtr-miR-130b	MIMAT0003593	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000034_1	22 / 0 / 22
xtr-miR-146a	MIMAT0003604	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000103_1	51 / 0 / 51
xtr-miR-182-3p	MIMAT0003611	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000116_2	6 / 0 / 6
xtr-miR-184	MIMAT0003613	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000059_1	20 / 0 / 20
xtr-miR-1b	MIMAT0003648	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000038_1	31 / 0 / 31
xtr-miR-204	MIMAT0003696	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000042_1	27 / 0 / 27
xtr-miR-23b	MIMAT0003673	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000027_1	34 / 0 / 34
xtr-miR-26	MIMAT0003569	1.0e-3	1.0e-3	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000043_1	69 / 0 / 69
hsa-miR-4443	MIMAT0018961	2.2e-2	2.2e-2	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	Not available	23 / 0 / 23
hsa-miR-513b-5p	MIMAT0005788	2.3e-2	2.3e-2	Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.	MIPF0000130_1	65 / 0 / 65
#N/A	MIMAT0022734	0.0e+0	2.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8
#N/A	MIMAT0022734	0.0e+0	2.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8
#N/A	MIMAT0022944	0.0e+0	9.1e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8
#N/A	MIMAT0022944	0.0e+0	8.5e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8
hsa-let-7a-5p	MIMAT0000062	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000002_1	115 / 0 / 115
hsa-let-7a-5p	MIMAT0000062	0.0e+0	3.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000002_1	115 / 0 / 115
hsa-let-7b-5p	MIMAT0000063	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000002_1	115 / 0 / 115
hsa-let-7b-5p	MIMAT0000063	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000002_1	115 / 0 / 115
hsa-let-7f-5p	MIMAT0000067	0.0e+0	3.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000002_1	115 / 0 / 115
hsa-let-7f-5p	MIMAT0000067	0.0e+0	4.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000002_1	115 / 0 / 115
hsa-let-7g-5p	MIMAT0000414	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000002_1	115 / 0 / 115
hsa-let-7i-5p	MIMAT0000415	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000002_1	115 / 0 / 115
hsa-let-7i-5p	MIMAT0000415	0.0e+0	2.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000002_1	115 / 0 / 115
hsa-miR-100-5p	MIMAT0000098	0.0e+0	1.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000033_1	91 / 0 / 91
hsa-miR-100-5p	MIMAT0000098	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000033_1	91 / 0 / 91
hsa-miR-106b-5p	MIMAT0000680	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000001_1	99 / 0 / 99
hsa-miR-106b-5p	MIMAT0000680	0.0e+0	4.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000001_1	99 / 0 / 99
hsa-miR-107	MIMAT0000104	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000024_1	70 / 0 / 70
hsa-miR-107	MIMAT0000104	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000024_1	70 / 0 / 70
hsa-miR-10a-5p	MIMAT0000253	0.0e+0	3.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000033_1	91 / 0 / 91
hsa-miR-1185-1-3p	MIMAT0022838	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000018_2	89 / 0 / 89
hsa-miR-1185-1-3p	MIMAT0022838	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000018_2	89 / 0 / 89
hsa-miR-1202	MIMAT0005865	0.0e+0	1.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000613_1	48 / 0 / 48
hsa-miR-1202	MIMAT0005865	0.0e+0	1.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000613_1	48 / 0 / 48
hsa-miR-1207-5p	MIMAT0005871	0.0e+0	2.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000596_1	52 / 0 / 52
hsa-miR-1207-5p	MIMAT0005871	0.0e+0	1.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000596_1	52 / 0 / 52
hsa-miR-1224-5p	MIMAT0005458	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000440_1	73 / 0 / 73
hsa-miR-1224-5p	MIMAT0005458	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000440_1	73 / 0 / 73
hsa-miR-1225-5p	MIMAT0005572	0.0e+0	1.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000445_1	57 / 0 / 57
hsa-miR-1225-5p	MIMAT0005572	0.0e+0	1.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000445_1	57 / 0 / 57
hsa-miR-1226-5p	MIMAT0005576	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000444_1	18 / 0 / 18
hsa-miR-1227-5p	MIMAT0022941	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000454_1	31 / 0 / 31
hsa-miR-1227-5p	MIMAT0022941	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000454_1	31 / 0 / 31
hsa-miR-1228-5p	MIMAT0005582	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000924_1	25 / 0 / 25
hsa-miR-1229-5p	MIMAT0022942	0.0e+0	1.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	13 / 0 / 13
hsa-miR-1229-5p	MIMAT0022942	0.0e+0	1.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	13 / 0 / 13
hsa-miR-1246	MIMAT0005898	0.0e+0	1.8e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000627_1	67 / 0 / 67
hsa-miR-1246	MIMAT0005898	0.0e+0	9.8e-4	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000627_1	67 / 0 / 67
hsa-miR-125a-3p	MIMAT0004602	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000033_2	63 / 0 / 63
hsa-miR-125b-5p	MIMAT0000423	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000033_1	91 / 0 / 91
hsa-miR-126-3p	MIMAT0000445	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000115_2	68 / 0 / 68
hsa-miR-1260a	MIMAT0005911	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001020_1	40 / 0 / 40
hsa-miR-1260a	MIMAT0005911	0.0e+0	1.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001020_1	40 / 0 / 40
hsa-miR-1260b	MIMAT0015041	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001381_1	38 / 0 / 38
hsa-miR-1260b	MIMAT0015041	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001381_1	38 / 0 / 38
hsa-miR-1268a	MIMAT0005922	0.0e+0	4.2e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000946_1	71 / 0 / 71
hsa-miR-1268a	MIMAT0005922	0.0e+0	5.1e-3	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000946_1	71 / 0 / 71
hsa-miR-1268b	MIMAT0018925	0.0e+0	4.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	15 / 0 / 15
hsa-miR-1268b	MIMAT0018925	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	15 / 0 / 15
hsa-miR-1273g-3p	MIMAT0022742	0.0e+0	3.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000579_2	15 / 0 / 15
hsa-miR-1275	MIMAT0005929	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000674_1	48 / 0 / 48
hsa-miR-1275	MIMAT0005929	0.0e+0	2.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000674_1	48 / 0 / 48
hsa-miR-128-3p	MIMAT0000424	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000048_2	30 / 0 / 30
hsa-miR-1287-5p	MIMAT0005878	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000725_1	25 / 0 / 25
hsa-miR-1287-5p	MIMAT0005878	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000725_1	25 / 0 / 25
hsa-miR-1290	MIMAT0005880	0.0e+0	3.8e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000610_1	41 / 0 / 41
hsa-miR-1290	MIMAT0005880	0.0e+0	1.5e-3	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000610_1	41 / 0 / 41
hsa-miR-130a-3p	MIMAT0000425	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000034_2	74 / 0 / 74
hsa-miR-130a-3p	MIMAT0000425	0.0e+0	2.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000034_2	74 / 0 / 74
hsa-miR-130b-3p	MIMAT0000691	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000034_2	74 / 0 / 74
hsa-miR-134-5p	MIMAT0000447	0.0e+0	4.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000112_1	43 / 0 / 43
hsa-miR-134-5p	MIMAT0000447	0.0e+0	4.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000112_1	43 / 0 / 43
hsa-miR-135a-3p	MIMAT0004595	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000028_2	39 / 0 / 39
hsa-miR-144-3p	MIMAT0000436	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000093_2	36 / 0 / 36
hsa-miR-144-3p	MIMAT0000436	0.0e+0	4.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000093_2	36 / 0 / 36
hsa-miR-148b-3p	MIMAT0000759	0.0e+0	4.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000056_2	57 / 0 / 57
hsa-miR-150-3p	MIMAT0004610	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000197_2	32 / 0 / 32
hsa-miR-150-3p	MIMAT0004610	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000197_2	32 / 0 / 32
hsa-miR-150-3p	MIMAT0004610	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000197_2	32 / 0 / 32
hsa-miR-150-3p	MIMAT0004610	0.0e+0	4.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000197_2	32 / 0 / 32
hsa-miR-151a-5p	MIMAT0004697	0.0e+0	5.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000057_1	60 / 0 / 60
hsa-miR-151b	MIMAT0010214	0.0e+0	2.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000057_1	60 / 0 / 60
hsa-miR-151b	MIMAT0010214	0.0e+0	1.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000057_1	60 / 0 / 60
hsa-miR-1587	MIMAT0019077	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	25 / 0 / 25
hsa-miR-15a-5p	MIMAT0000068	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000006_1	113 / 0 / 113
hsa-miR-15a-5p	MIMAT0000068	0.0e+0	3.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000006_1	113 / 0 / 113
hsa-miR-15b-5p	MIMAT0000417	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000006_1	113 / 0 / 113
hsa-miR-15b-5p	MIMAT0000417	0.0e+0	4.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000006_1	113 / 0 / 113
hsa-miR-16-5p	MIMAT0000069	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000006_1	113 / 0 / 113
hsa-miR-16-5p	MIMAT0000069	0.0e+0	3.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000006_1	113 / 0 / 113
hsa-miR-17-5p	MIMAT0000070	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000001_1	99 / 0 / 99

< [569] [570] [571] [572] [573] [574] [575] [576] [577] [578] >